TABLE 1.
Disorder | Cellular process | Mediators | Model | References |
---|---|---|---|---|
Acute lung injury | Proliferation, apoptosis, oxidative stress response, inflammatory response | miR‐223, NLRP3, miR‐26a‐5p, TLR4 | Cell lines, animal models | 180 , 181 |
Asthma | Apoptosis regulation, inflammatory response, miRNA regulation | miR‐143‐3p, HMGB1 | Cell lines, clinical specimens | 79 , 80 |
Atherosclerosis | miRNA regulation, apoptosis regulation | miR‐320a, LOX1 | Cell lines and clinical specimens | 98 |
Bipolar disorder | Unknown, potential biomarker based on expression | Unknown | Cell lines and clinical specimens | 83 |
Cataracts | Apoptosis, oxidative stress | HuR, POLG | Cell lines | 73 |
Cardiac failure | Mitochondrial function, stress response in female animals | Unknown | Cell lines and animal models | 109 |
Diabetic nephropathy | Apoptosis, proliferation, fibrosis | miR‐34a‐5p, Sirt1, HIF‐1α | Cell lines and animal models | 54 |
Diabetic angiopathy | Apoptosis, cognitive function | miR‐200b, ACE2 | Cell lines and animal models | 57 |
Diabetic retinopathy | Apoptosis | miR‐449c | Cell lines and clinical specimens | 59 |
Intervertebral disk degeneration | Proliferation, extracellular matrix accumulation | Unknown | Cell lines and clinical specimens | 72 |
Myocardial ischaemia | Apoptosis | miR‐297a, CGRP, miR‐29a, SIRT1 | Cell lines and animal models | 2 , 62 |
Osteoarthritis | Inflammatory response regulation, apoptosis, migration, proliferation | miR‐30a‐5p, miR‐29b‐3p, PGRN | Cell lines and clinical specimens | 66 , 182 |
Periodontitis | Inflammatory response | Unknown | Cell lines and clinical specimens | 76 |
Parkinson's disease | Alpha‐synuclein toxicity and aggregation, apoptosis, autophagy, endoplasmic reticulum stress | miR‐126 | Cell lines and clinical specimens | 92 |
Rheumatoid arthritis | Inflammatory response regulation, apoptosis | miR‐448, PON1 | Cell lines and clinical specimens | 65 |
Schizophrenia | Disease predictor in females | Unknown | Cell lines and clinical specimens | 22 |
Abbreviations: CGRP, calcitonin gene‐related peptide; LOX1, lectin‐like oxidised low‐density lipoprotein 1; PGRN, progranulin; PON1, paraoxonase 1; Sirt1, silent information regulator T1.